MapLight Therapeutics, Inc. (MPLT)
29.97
+2.17
(+7.81%)
USD |
NASDAQ |
Jun 11, 14:41
MapLight Therapeutics EPS Diluted (Quarterly) : -1.342 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -1.342 |
| December 31, 2025 | -1.807 |
| September 30, 2025 | -0.6484 |
| June 30, 2025 | -0.7204 |
| Date | Value |
|---|---|
| March 31, 2025 | -0.4924 |
| June 30, 2024 | -0.4441 |
| March 31, 2024 | -0.457 |
| March 31, 2023 | -0.2892 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Mineralys Therapeutics, Inc. | -0.4749 |
| Evommune, Inc. | -0.6437 |
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Oncolytics Biotech, Inc. | -0.0823 |
| Sangamo Therapeutics, Inc. | -0.0796 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -60.67M |
| Total Expenses (Quarterly) | 60.67M |
| Enterprise Value | 952.29M |
| Earnings Yield | -15.07% |
| Normalized Earnings Yield | -15.07 |